Bilateral male breast cancer with male potential hypogonadism

Department of Oncological and Regenerative Surgery, Institute of Health Biosciences, The University of Tokushima, 3-18-15, Kuramoto-Cho, Tokushima 770-8509, Japan.
World Journal of Surgical Oncology (Impact Factor: 1.41). 02/2007; 5(1):60. DOI: 10.1186/1477-7819-5-60
Source: PubMed


Male breast cancer is a comparatively rare disease, and simultaneous bilateral male breast cancer is considered to be an extremely rare event. Risk factors are said to be genetic factors and hormonal abnormalities due to obesity or testicular diseases.
The patient was a 47-year-old Japanese male. His family had no history of female breast cancer. This patient also had hypospadias and hormonal examination indicated the presence of primary testicular potential hypogonadism, and these hormonal abnormalities seemed to be present since childhood or the fetal period. The bilateral breast cancer developed in this man at a comparatively young age, and histopathological studies of multiple sections showed that there was almost no normal epithelial cell in the ducts, while the ducts were almost completely filled with breast cancer cells.
It is thought that male breast cancer is caused by an imbalance between estrogen and testosterone. We cannot rule out the possibility that the breast cancer developed due to the effect of the slight elevation of estrogen over a long period of time, but the actual causative factors in this patient were unable to be definitively identified. In the future, we hope to further elucidate the causes of male breast cancer.

Download full-text


Available from: Akira Tangoku, Oct 10, 2015
17 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Male breast cancer is an uncommon condition. It often occurs in settings in which there is an imbalance between androgens and oestrogens. Genetics plays an important role, as many cases are associated with mutations in BRCA2 or other genes. Male breast cancer occurs at an older age than female breast cancer and is frequently diagnosed at a later stage. Tumors are predominantly oestrogen and progesterone positive. Prognosis is approximately equivalent to that of breast cancer in females when matched for age, stage and hormonal receptors. The recommended treatment for male breast cancer is similar to that for breast cancer in postmenopausal females. However, the presence of androgens in males has a strong effect on the hormonal milieu and the ability of male patients to respond to hormonal agents. When pharmacologic treatment is required, tamoxifen is effective for first-line therapy. Other hormonal approaches such as orchiectomy, aromatase inhibitors and androgen ablation may be useful in later lines of therapy.
    Expert Opinion on Pharmacotherapy 09/2009; 10(15):2499-510. DOI:10.1517/14656560903200634 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The Male Breast Cancer (MBC) is a very rare neoplasm which accounts for 0.5- 1% of the total cases of breast cancer. Bilateral involvement is reported to occur in fewer than 2% of all the diagnosed cases of MBC, and synchronous tumors are very rare. Because of its rarity, little is known about MBC etiology, its clinical findings and treatment. Most patients present with a painless breast mass. The prognosis does not seem to be poor compared to that of the females, and it probably has a similar stage by stage prognosis. Surgical treatment is the gold standard for MBC. The authors report a case of simultaneous bilateral male breast cancer. The aim of this case report was to contribute to the available literature by this unusual presentation of the disease.
    Iranian Journal of Cancer Prevention 01/2010; 3(4).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Men with Klinefelter syndrome have one or more extra X chromosomes and have endocrine abnormalities. Klinefelter syndrome has been consistently associated with breast cancer in men (MBC). We report a 54-year old man was diagnosed as synchronous bilateral breast cancer with Klinefelter syndrome. On clinical examination there was mass in the lateral upper quadrant right breast. The overlying skin was slightly retracted. In the left breast, there was also a subareolar mass. Mammography, ultrasonography imaging showed bilateral suspicious breast masses with microcalcifications. There were no radiological findings of muscle invasion or axillary lymphadenopathy. We performed bilateral fine-needle aspiration biopsy (FNAB), and the aspiration smears were positive for carcinoma. The pathologic diagnosis of infiltrating ductal carcinoma in the biopsy specimen on the bilateral breast. The patient was successfully treated by bilateral radical modified mastectomy according to Madden's technique followed by external irradiation and adjuvant endocrine therapy. Breast cancer commonly occurs in women, but now the incidence is also seen in men. Risk factors include age, family history, genes, liver diseases (cirrhosis), alcohol, diet, and obesity. Klinefelter syndrome, in which patients carry XXY chromosome, may be present in men with breast cancer for this reason they often develop gynecomastia.
    Medical Archives 01/2010; 64(4):250-2.
Show more